NVC-001 is designed to target the mechanobiological root cause of LMNA dilated cardiomyopathy and has disease-modifying potential SINGAPORE, PARIS and PHILADELPHIA, Oct. 8, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company pioneering mechanobiology-targeted therapies designed to address the root causes of life-threatening cardiomyopathies, today announced that the first...
LOS ANGELES, March 31, 2025 /PRNewswire/ -- With remote and hybrid work rapidly becoming the new normal, high-quality video conferencing tools are essential for...
TAIPEI, March 31, 2025 /PRNewswire/ -- As the AI PC era accelerates, GIGABYTE announces its flagship AI gaming laptops, the AORUS MASTER 18 and AORUS MASTER...
HONG KONG, March 31, 2025 /PRNewswire/ -- China Renaissance Holdings Limited ("China Renaissance" or the "Group", stock code: 1911.HK) today announced its annual results...
